Back Klausen, MK, Jensen, ME, Mller, M, et al (6 Sept 2022) 'Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial', JCI Insight, 7/19, e159863
This trial underscores the expanding scope of incretin therapy beyond simple weight management, a trend also visible in the growing body of research on peptides for athletic performance and recovery
This result highlights the potential of combined therapy with hepsin and NAC to treat APAP-induced liver injury, paving the way for promising future research
BMC Complement Altern Med 18(1):63 Peterson ME (2014) Animal models of disease: feline hyperthyroidism: an animal model for toxic nodular goiter
All treatments are subject to provider review, medical appropriateness, and clinical discretion